Prostatic chondroitin sulfate is increased in patients with metastatic disease but does not predict survival outcome. | EBSCOhost

Connecting you to content on EBSCOhost

Title: Prostatic chondroitin sulfate is increased in patients with metastatic disease but does not predict survival outcome.
Authors: Ricciardelli, Carmela; Sakko, Andrew J.; Stahl, Jürgen; Tilley, Wayne D.; Marshall, Villis R.; Horsfall, David J.
Publication: Prostate, 2009, Vol 69, Issue 7, p761
ISSN: 0270-4137
Publication type: Academic Journal
DOI: 10.1002/pros.20926